Effect of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis.
D011464:Epoprostenol / Q000494:pharmacology*; D004912:Erythrocytes / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D011453:Prostaglandins / Q000494:pharmacology*; D011458:Prostaglandins E / Q000494:pharmacology*; D011928:Raynaud Disease / Q000097:blood* / Q000209:etiology; D012595:Scleroderma, Systemic / Q000097:blood* / Q000150:complications
D011453:Prostaglandins; D011458:Prostaglandins E; D011464:Epoprostenol